(MENAFN- GlobeNewsWire - Nasdaq) The Europe Next-Generation Interventional Cardiology Market is set to surge from USD 5.80 billion in 2024 to USD 13.06 billion by 2035, registering a CAGR of 7.66% from 2025 to 2035. Revolutionizing cardiac care, these minimally invasive techniques combat valvular diseases, coronary artery disease, and structural heart defects with precision-guided methods. Driven by technological advancements in robotics and AI-enhanced imaging, Europe is shifting from traditional surgeries to catheter-based interventions. Supporting healthcare's evolution, these developments improve patient outcomes, optimize resources, and meet the demands of an aging population.

Dublin, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The "Europe Next-Generation Intervention Cardiology Market: Focus on Product Type, Indication Type, End User, and Country - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets's offering.
The Europe next-generation intervention cardiology market is projected to reach USD 13.06 billion by 2035 from USD 5.80 billion in 2024, growing at a CAGR of 7.66% during the forecast period 2025-2035.

The Europe Next-Generation Interventional Cardiology Market is undergoing a rapid transformation as healthcare systems prioritize minimally invasive, patient-centric solutions for managing complex cardiovascular diseases. Advanced catheter-based operations are increasingly replacing open heart surgeries as the primary source of morbidity and mortality in Europe due to cardiovascular illnesses such coronary artery disease, structural heart abnormalities, and valvular disorders. The region's focus on enhancing patient outcomes, cutting hospital stays, and making the most of healthcare resources is what is causing this change.

Robotics, AI-powered imaging, 3D navigation, and advanced device technologies are all used in next-generation interventional cardiology to improve accuracy, safety, and procedural efficiency. Healthcare facilities throughout Europe are adopting innovations including drug-coated balloons, bioresorbable scaffolds, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve repair (TMVR) at an increasing rate. The spread of these cutting-edge therapies is further supported by the establishment of hybrid cath laboratories and ambulatory facilities, which provide greater accessibility for patients.
Regulatory frameworks, including the EU MDR (Medical Device Regulation), are shaping product approvals by enforcing higher safety standards and clinical validation. Coupled with rising healthcare investments, an aging population, and strong R&D collaborations between medtech companies and academic institutions, Europe is positioned as a key hub for next-generation interventional cardiology innovation and adoption.

How can this report add value to an organization?

• Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in Europe next-generation intervention cardiology, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.
• Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.
• Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in Europe next-generation intervention cardiology and allowing them to strategize effectively to gain a competitive edge in the market.
• Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to Europe next-generation intervention cardiology, ensuring organizations stay compliant and accelerate market entry for new next-generation intervention cardiology
• Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Europe Next-Generation Intervention Cardiology Market Trends, Drivers and Challenges

Trends

• Growing adoption of minimally invasive procedures using next-gen stents, balloons, and catheters.
• Expansion of transcatheter therapies (e.g., TAVR, TMVR) as alternatives to open-heart surgery.
• Integration of robotics and image-guided systems to enhance precision and reduce complications.
• Rising use of drug-coated balloons, bioresorbable scaffolds, and novel stent materials.
• Increasing application of AI, machine learning, and 3D imaging in procedure planning and real-time guidance.
• Strong growth in ambulatory cardiac care centers and hybrid operating rooms across Europe.

Drivers

• High prevalence of cardiovascular diseases due to aging populations and lifestyle factors.
• Growing demand for less invasive, faster-recovery treatments compared to conventional surgery.
• Technological innovation supported by European medical device companies and research institutions.
• Supportive EU healthcare policies and reimbursement frameworks for advanced cardiac interventions.
• Rising investments in digital health, telecardiology, and remote patient monitoring.
• Increasing awareness and early diagnosis of coronary and structural heart diseases.

Challenges

• High cost of next-gen interventional devices and robotic systems limiting access in some regions.
• Variability in reimbursement policies across EU member states.
• Steep learning curve and training requirements for interventional cardiologists adopting new technologies.
• Regulatory hurdles for CE marking and EU MDR compliance delaying product launches.
• Competition from conventional procedures and alternative therapies.
• Limited availability of infrastructure such as hybrid cath labs in smaller hospitals.

Key Attributes:

Report Attribute	Details
No. of Pages	87
Forecast Period	2025 - 2035
Estimated Market Value (USD) in 2025	$6126.7 Million
Forecasted Market Value (USD) by 2035	$13063 Million
Compound Annual Growth Rate	7.6%
Regions Covered	Europe

Key Market Players and Competition Synopsis

• B. Braun SE
• Koninklijke Philips N.V.
• Siemens Healthineers AG

Market Segmentation

Product Type

Robotics

• Robotic-Assisted Percutaneous Coronary Intervention (R-PCI)
• Robotic-Assisted Coronary Artery Bypass Grafting (RA-CABG)
• Robotic Assisted Mitral Valve-Replacement (RMVR)
• Robotic Assisted Aortic Valve Replacement

Non-Robotics

• IVUS
• OCT
• Other Interventions
  • Stents
  • Catheters
  • Guidewires
  • PTCA Balloons
  • Others

Indication Type

• Structural Heart Disease
• Coronary Heart Diseases
• Valvular Heart Diseases
• Peripheral Artery Diseases
• Congenital Heart Diseases

End User

• Hospitals and Clinics
• Cardiac Centers
• Ambulatory Surgical Centers

Region

• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• European Next-Generation Intervention Cardiolog Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN13102025004107003653ID1110187020